445 related articles for article (PubMed ID: 31167470)
1. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
[TBL] [Abstract][Full Text] [Related]
3. Current Insights into Mesenchymal Signatures in Glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Date I
Acta Med Okayama; 2022 Oct; 76(5):489-502. PubMed ID: 36352795
[TBL] [Abstract][Full Text] [Related]
4. Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.
Segerman A; Niklasson M; Haglund C; Bergström T; Jarvius M; Xie Y; Westermark A; Sönmez D; Hermansson A; Kastemar M; Naimaie-Ali Z; Nyberg F; Berglund M; Sundström M; Hesselager G; Uhrbom L; Gustafsson M; Larsson R; Fryknäs M; Segerman B; Westermark B
Cell Rep; 2016 Dec; 17(11):2994-3009. PubMed ID: 27974212
[TBL] [Abstract][Full Text] [Related]
5. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication.
Iwadate Y
Neurol Med Chir (Tokyo); 2018 Feb; 58(2):61-70. PubMed ID: 29129882
[TBL] [Abstract][Full Text] [Related]
6. Perspective of mesenchymal transformation in glioblastoma.
Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH
Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019
[TBL] [Abstract][Full Text] [Related]
7. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
8. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
9. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
10. CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
Khan AB; Lee S; Harmanci AS; Patel R; Latha K; Yang Y; Marisetty A; Lee HK; Heimberger AB; Fuller GN; Deneen B; Rao G
Int J Cancer; 2023 Feb; 152(4):713-724. PubMed ID: 36250346
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation.
Karsy M; Guan J; Jensen R; Huang LE; Colman H
World Neurosurg; 2016 Apr; 88():222-236. PubMed ID: 26724617
[TBL] [Abstract][Full Text] [Related]
12. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
13. The adaptive transition of glioblastoma stem cells and its implications on treatments.
Wang Z; Zhang H; Xu S; Liu Z; Cheng Q
Signal Transduct Target Ther; 2021 Mar; 6(1):124. PubMed ID: 33753720
[TBL] [Abstract][Full Text] [Related]
14. Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.
Teng J; da Hora CC; Kantar RS; Nakano I; Wakimoto H; Batchelor TT; Chiocca EA; Badr CE; Tannous BA
Neuro Oncol; 2017 Jun; 19(6):820-832. PubMed ID: 28062830
[TBL] [Abstract][Full Text] [Related]
15. The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.
Iser IC; Pereira MB; Lenz G; Wink MR
Med Res Rev; 2017 Mar; 37(2):271-313. PubMed ID: 27617697
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition.
Xu C; Hou P; Li X; Xiao M; Zhang Z; Li Z; Xu J; Liu G; Tan Y; Fang C
Cancer Biol Med; 2024 May; 21(5):363-81. PubMed ID: 38712813
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions.
Lai Y; Lu X; Liao Y; Ouyang P; Wang H; Zhang X; Huang G; Qi S; Li Y
Genes Dis; 2024 Mar; 11(2):874-889. PubMed ID: 37692522
[TBL] [Abstract][Full Text] [Related]
18. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
Olmez I; Love S; Xiao A; Manigat L; Randolph P; McKenna BD; Neal BP; Boroda S; Li M; Brenneman B; Abounader R; Floyd D; Lee J; Nakano I; Godlewski J; Bronisz A; Sulman EP; Mayo M; Gioeli D; Weber M; Harris TE; Purow B
Neuro Oncol; 2018 Jan; 20(2):192-202. PubMed ID: 29048560
[TBL] [Abstract][Full Text] [Related]
19. A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma.
Qi T; Meng X; Wang Z; Wang X; Sun N; Ming J; Ren L; Jiang C; Cai J
Front Oncol; 2021; 11():595259. PubMed ID: 33816228
[No Abstract] [Full Text] [Related]
20. Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis.
Zhang Y; Xu L; Wang P; Jian H; Shi X; Jia M; Mo L; Hu Z; Li H; Li J
Cell Cycle; 2019 Aug; 18(16):1938-1947. PubMed ID: 31234753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]